Results

Total Results: 597 records

Showing results for "risk".

  1. srdr.ahrq.gov/projects/1312/studies/147778
    January 01, 2015 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status Adults at an increased risk
  2. srdr.ahrq.gov/projects/1609/studies/198657
    January 01, 1992 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  3. srdr.ahrq.gov/projects/1609/studies/198620
    January 01, 2001 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  4. srdr.ahrq.gov/projects/1520/studies/186803
    January 01, 2017 - Yes Low risk of detection bias because outcome assessors were blinded (NCT). … Comments ( 0 ) | Post/View Q6: ROBINS-I - Risk of bias judgement for BIAS DUE TO CONFOUNDING … Comments ( 0 ) | Post/View Q13: ROBINS-I - Risk of bias judgement for BIAS IN SELECTION OF … Yes Low risk of detection bias because patients were blinded.
  5. srdr.ahrq.gov/projects/1609/studies/198618
    interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  6. srdr.ahrq.gov/projects/1609/studies/198655
    January 01, 2005 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  7. srdr.ahrq.gov/projects/1609/studies/198617
    January 01, 1996 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  8. srdr.ahrq.gov/projects/1609/studies/198654
    January 01, 2007 - effectiveness of screening for hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  9. srdr.ahrq.gov/projects/1609/studies/198637
    January 01, 2017 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  10. srdr.ahrq.gov/projects/1705/studies/197229
    January 01, 2001 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  11. srdr.ahrq.gov/projects/1705/studies/197228
    January 01, 1996 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  12. srdr.ahrq.gov/projects/1705/studies/197227
    January 01, 2007 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  13. srdr.ahrq.gov/projects/1705/studies/197223
    January 01, 2006 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  14. srdr.ahrq.gov/projects/1671
    January 08, 2021 - Compared with placebo, triptans resolved pain at 2 hours and 1 day, and increased the risk of mild and … Compared with placebo, NSAIDs probably resolved pain at 2 hours and 1 day, and increased the risk of … No studies evaluated instruments for predicting risk of opioid misuse, opioid use disorder or overdose … , or evaluated risk mitigation strategies to be used when prescribing opioids for the acute treatment … Data can be found in the following links: https://srdr.s3.amazonaws.com/uploads/01-08-2021/SRDR+-+Risk
  15. srdr.ahrq.gov/projects/1609/studies/198619
    January 01, 2010 - effectiveness of screening for hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  16. srdr.ahrq.gov/projects/1609/studies/198656
    January 01, 2005 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
  17. srdr.ahrq.gov/projects/1705/studies/197224
    January 01, 2014 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  18. srdr.ahrq.gov/projects/1705/studies/197225
    intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  19. srdr.ahrq.gov/projects/1705/studies/197226
    January 01, 1997 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
  20. srdr.ahrq.gov/projects/1312/studies/133174
    January 01, 2013 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … all overweight (BMI 25+), but not obese- not sure if should count as increased risk?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: